Founded in 2002
MedImmune is the global biologics research and development arm of AstraZeneca, a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of small molecule and biologic prescription medicines. MedImmune is pioneering innovative research an...
Jorge Conde
Marketing & Operations Manager
Jane Osbourn Obe
VP Research and Development; Site Leader Cambridge UK
Anand Subramony
Vice President, Drug Delivery & Device Development
Trish Palini
Director, Sales & Marketing Operations
Simon Lennard
Global Director of Project Management, R&D
Micki Hultquist
Sr. Director, Clinical Statistics
Gary Cline
Vice President of Biostatistics, Programming and Data Management
Karen King
Sr. Project Manager
Ann E. Taylor, M.D.
Vice President, Global Clinical Development